Roche Partners with DNA Electronics to Help Migrate 454 Platform to Electrochemical Detection

Roche said the new platform will "build on 454 Life Sciences’ current pyrosequencing-based sequencing platforms by enabling a seamless evolution from optical detection to inexpensive, highly scalable electrochemical detection."

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.